JPH09202A - Food for stress - Google Patents

Food for stress

Info

Publication number
JPH09202A
JPH09202A JP7184605A JP18460595A JPH09202A JP H09202 A JPH09202 A JP H09202A JP 7184605 A JP7184605 A JP 7184605A JP 18460595 A JP18460595 A JP 18460595A JP H09202 A JPH09202 A JP H09202A
Authority
JP
Japan
Prior art keywords
spirulina
stress
health
food
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7184605A
Other languages
Japanese (ja)
Inventor
Minoru Yoneda
實 米田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP7184605A priority Critical patent/JPH09202A/en
Publication of JPH09202A publication Critical patent/JPH09202A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Seaweed (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

(57)【要約】 【目的】生活近代化に伴い増加する健康阻害要因による
侵襲を、ストレスへの耐性を賦活することで軽減する食
品組成物を提供することを目的としている。 【構成】スピルリナを主としながら、複数の補気性生薬
を配合することでスピルリナの機能性がより確実に発現
されるようにした。
(57) [Summary] [Objective] An object of the present invention is to provide a food composition that reduces the invasion due to the health-inhibiting factors that increase with the modernization of life by activating the resistance to stress. [Structure] The main function of spirulina was to ensure that the functionality of spirulina is expressed more reliably by incorporating multiple herbal medicines.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はスピルリナに複数の補気
性生薬を配合したストレス対応食品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a food product for stress prepared by mixing a plurality of aspirative crude drugs with spirulina.

【0002】[0002]

【従来の技術】生活の近代化はその簡便さや快適さの代
償として、必然的に様々な健康阻害要因を副生する。エ
ネルギー消費に伴う大気汚染物質、食糧増産に付随する
農薬、環境美化に比例して使用が拡大する殺菌殺虫剤、
逐次的に紫外線を増しつつあるオゾン層破壊物質、対人
関係の過密化で蓄積するストレスなど、生活周辺健康阻
害要因の増勢は止めるすべもない。
2. Description of the Related Art The modernization of life inevitably produces various health-impairing factors as a by-product at the cost of convenience and comfort. Air pollutants associated with energy consumption, pesticides associated with increased food production, fungicides and insecticides whose use expands in proportion to environmental beautification,
There is no stopping the increase in factors that impair health around people's lives, such as ozone depleting substances that are gradually increasing ultraviolet rays and stress accumulated due to overcrowding of personal relationships.

【0003】これら健康阻害要因によるダメージは、何
人においても確実に加重されるのに、その進行が緩除な
ため対処の時を逸し易く、みすみす自他覚症状を顕在化
させてしまうことが少なくない。その時期にはすでに医
薬品などによる治療も余儀無くされ、医薬品の連用など
による副作用をはじめ、新たに多大なコストの要求を受
けるようになる。
The damage caused by these health-inhibiting factors is certainly weighted by any person, but since the progress is slow, it is easy to miss the time of coping, and the mischievous subjective symptoms are rarely manifested. Absent. At that time, treatment with drugs has already been unavoidable, and side effects such as continuous use of drugs will cause new demand for great costs.

【0004】先に述べた健康阻害要因は、二次的には全
てからだに対しその免疫のバランスを崩すストレスとし
て作用するが、その予防的対処のために、近時旺んに行
われつつある食品対象の機能検索も、食品一般の成分間
相互作用の複雑さにより、何れも効果再現における不確
実さを免れ難く、とりわけストレスに対応してからだの
ダメージをやわらげ得る食品は無きに等しい。
The health-inhibiting factor described above acts as a stress that secondarily imbalances the immune system of all the bodies, but it is recently being actively used to prevent it. In the functional search of food objects, it is difficult to avoid uncertainty in effect reproduction due to the complexity of interactions among ingredients in general foods, and in particular, there is no food that can reduce body damage in response to stress.

【0005】[0005]

【発明が解決しようとする課題】本発明は、その栄養成
分の種類や量やバランスにおいて、最も有用なものの一
つに数えられていながら、健康維持機能の再現性が人に
より不一であったスピルリナに、複数の補気性生薬を配
合することで、生活近代化に副生する心身のトラブル、
とりわけストレス蓄積によるからだの正常化能力減退
を、効果的に防ぎ得る食品を提供しようとするものであ
る。
The present invention is one of the most useful nutritional components in terms of type, amount, and balance, but the reproducibility of the health maintenance function is unsatisfactory for humans. By mixing multiple spirulina herbs with Spirulina, mental and physical problems that are a byproduct of modernization of life,
In particular, it aims to provide foods that can effectively prevent the decline in body normalizing ability due to stress accumulation.

【0006】[0006]

【課題を解決するための手段】本発明者がかねて研究を
続けてきたスピルリナは、健康を維持する食品として長
い摂食の歴史があるが、その効用の現われは人により差
が大きく、折角健康維持を志向して摂取をはじめても、
その中断によつて健康基盤強化努力を徒労に終わらせて
しまうことが多い。いうまでもなくこれは健康維持目的
で利用される食品に通有のことでもあるが、環境劣化に
加え健康保険財政の破綻見込なども濃厚で、プライマリ
ーヘルスケアの要請が切実な今、最も栄養バランスに優
れるスピルリナの機能性発現率を高めることを急務とし
て、スピルリナに様々な食材を配合し試行錯誤を重ねた
結果、複数の補気性生薬の添加が、スピルリナ単味の摂
取で果たせなかった健康維持機能の再現性アップをはか
り得ることを見出し、本発明をなすに至った。
[Means for Solving the Problems] Spirulina, which the present inventor has continued to study for a long time, has a long history of eating as a food for maintaining health, but the effect of the effect varies greatly from person to person. Even if you start taking it with the intention of maintaining it,
The interruption often ends the effort to strengthen the health infrastructure in vain. Needless to say, this is common in foods used for the purpose of maintaining health, but there is a strong expectation that the financial health insurance will collapse in addition to environmental deterioration, and nowadays there is a strong demand for primary health care, and it is the most nutritious. As a matter of urgent need to increase the functional expression rate of Spirulina, which has a good balance, we have mixed various ingredients into Spirulina and conducted trial and error. They have found that the reproducibility of the maintenance function can be improved, and have completed the present invention.

【0007】本発明はさらに、スピルリナに、補気性生
薬のうち人参、甘草、霊芝をセットとして配合した食品
を提供する。
[0007] The present invention further provides a food containing spirulina as a set of carrot herbs such as ginseng, licorice and reishi.

【0008】[0008]

【具体的な説明】まず本発明でいうスピルリナは、藍藻
類紐子目スピルリ属のスピルリナでバクテリアに由来す
る藻類であるが、従来食用されている何れの使用も可と
する中で、スピルリナ・マキシマ(Spirulina
maxima)の使用を最も好ましくする。
[Detailed Description] First, the spirulina referred to in the present invention is an alga derived from bacteria in the genus Spirulina of the genus Spirulina of the genus Cyanophyta. Maxima (Spirulina)
Most preferred is the use of maxima).

【0009】さらに本発明でいう補気性生薬は、漢方医
学(中国伝統医学)に用いられてきた生薬のうち温性と
甘性(保温性と滋養性)を兼ね有するもので、人参(P
anax ginseng)、黄耆(Asutraga
lasmembranaceus)、党参(Codon
opsis pilosula)、山薬(Diosco
rea batatas)、白朮(Atractylo
des batataS)、大棗(Zizyphus
jujuba)、甘草(Glycyrrhiza ur
alensis)、膠飴(Saccharum gra
norum)、紫河車(Placenta homin
is)、霊芝(Ganoderma japonicu
m)、杜仲(Eucommia ulmoides)、
胡桃肉(Juglans regia)、冬虫夏草(C
ordyceps sinensis)などを指す。
「漢薬の臨床応用・・・神戸中医学研究会、訳・編、医
歯薬出版(株)刊」の分類。なおこれら生薬の使用形態
は、一般の漢方薬におけると同じく、原末としても抽出
物としても本発明の効果を阻害するものではない。
Further, the replenishing herbal medicine as referred to in the present invention is a herbal medicine that has been used in Chinese medicine (Chinese traditional medicine) and has both warmness and sweetness (heat retention and nourishment).
anax ginseng), Astragalus (Asutraga)
lasmembranaceus), Party Participants (Codon
opsis pilosula), mountain herb (Diosco)
rea batatas), Shiroyaku (Atractylo)
des batataS), Ojumu (Zyiffus)
Jujuba), licorice (Glycyrrhiza ur)
alensis), candy candy (Saccharum gra)
norum), Shikawa (Placenta homin)
is), Reishi (Ganoderma japonicu)
m), Eucommia ulmoides,
Walnut meat (Juglans regia), Cordyceps (C)
ordyceps sinensis).
Classification of "Clinical application of Chinese medicine ... Kobe Chinese Medicine Study Group, translation / edition, published by Ito Denryaku Publishing Co., Ltd." The use form of these crude drugs does not impair the effects of the present invention, either as a bulk powder or an extract, as in common Chinese herbs.

【0010】まずいくつかの調査によるスピルリナ単味
の継続摂取による愁訴の改善は、男性では血液の栄養作
用に、女性では発汗機能のバランスに現われやすいなど
の性差がみられ、改善率も過半を上回るものではない。
もとより健康維持をはかる目的での摂取であるから、自
覚症状改善率をのみ判断基準とすべきでないが、プライ
マリーヘルスケアの実を上げるためには、日常生活での
健康阻害要因とくにストレスへの耐性においてすぐれ、
かつその現われ方に性差なきものへの指向が課題であ
る。
[0010] First of all, the improvement of complaints by continuous ingestion of spirulina alone by several studies showed a sex difference such as blood nutritional effects in men and a sweating function balance in women, and the improvement rate was more than half. It does not exceed.
Of course, since it is taken for the purpose of maintaining good health, the subjective symptom improvement rate should not be the only criterion, but in order to improve primary health care, health-inhibiting factors in daily life, especially tolerance to stress Good at,
Moreover, the issue is how to direct things that do not differ in their appearance.

【0011】以上のことにより本発明者は、最も光合成
をよくするという成り立ちと成分内容からみて、健康維
持にきわめて有用であるはずのスピルリナの、栄養およ
び機能に基づく効果をより確かに誘導し得る成分の検索
を、経験的また分析的に安全性データの揃った生薬類に
求め、単一または複数のそれのスピルリナへの添加によ
る機能誘導能のスクリーニングを繰り返し、スピルリナ
への添加がきわめてよくストレス蓄積のダメージを防
ぎ、かつそれが性差なく高率に再現される生薬の組合せ
を見出した。すなわち本発明でいうストレス対応食品と
しての、スピルリナに複数の補気性生薬を配したものが
それである。
From the above, the present inventor can more certainly induce the nutritional and function-based effects of spirulina, which should be extremely useful for maintaining health, in view of the mechanism that enhances photosynthesis most and the content of ingredients. Searching for ingredients was empirically and analytically requested for crude drugs with safety data, and repeated screening of function-inducing ability by adding single or multiple of them to Spirulina, and addition to Spirulina was extremely stressed. We have found a combination of crude drugs that prevent accumulation damage and that can be reproduced at a high rate without sex difference. That is, this is the one in which a plurality of aspirating crude drugs are arranged in spirulina as a food for stress according to the present invention.

【0012】先にも述べたように、生活近代化に伴い増
加する健康阻害要因は枚挙にいとまないが、全てストレ
スを及ぼして健康維持機能を減弱させることで総括し得
る。しかるにその対処法は、「ストレスをためないよう
に」とか「バランスのよい食事を」という助言と、ビタ
ミンやカルシウム服用の勧めだけで、実効はほとんど期
待し難い。ここに本発明者は、まず生体においてストレ
ス蓄積度に比例して産生能が低下するインターフェロン
γ(IFNγ)に着目し、本発明の食品組成物摂取によ
る健常人IFNγ産生とその効果発現の受け皿である2
−5A合成酵素の活化を測ってストレスへの耐性をみ、
次いでアトピー体質にあって、皮膚炎などの発症がスト
レスをきっかけとし易いことから、本発明食品組成物摂
取による血清中免疫グロブリンE(IgE)と皮膚炎症
状の推移をみて、ストレス耐性の消長を考察した。
[0012] As mentioned above, there are enumeration of health-inhibiting factors that increase with modernization of life, but they can be summarized by exerting stress and weakening the health maintenance function. However, the coping method is only to avoid stress and to have a balanced diet, and to recommend vitamins and calcium. Here, the present inventor first focused on interferon γ (IFNγ) whose productivity decreases in proportion to the degree of stress accumulation in the living body, and in the saucer of healthy human IFNγ production and its effect expression by ingesting the food composition of the present invention. There is 2
-5A synthase activation is measured to check resistance to stress,
Next, in the atopic constitution, since the onset of dermatitis is likely to be triggered by stress, the transition of serum immunoglobulin E (IgE) and dermatitis due to the ingestion of the food composition of the present invention is observed to improve the stress tolerance. I considered.

【0013】本発明の食品組成物において、主原料たる
スピルリナの配合量は乾燥粉末として30〜95重量%
が適当であり、配する各補気性生薬の量は、それぞれが
エキスとして0.3〜3重量%が適当である。これら生
薬エキスの抽出は、水または低級脂肪族アルコール類あ
るいは含水低級脂肪族アルコール類を用いての公知の何
れの方法によってもよく、また全体の組成において、さ
らに通常に食品への使用を可とされる原料の添加も、本
発明の効果に影響するものでない。
In the food composition of the present invention, the amount of spirulina as a main raw material is 30 to 95% by weight as a dry powder.
Is suitable, and the amount of each herbal medicine to be distributed is 0.3 to 3% by weight as an extract. Extraction of these crude drug extracts may be carried out by any known method using water or lower aliphatic alcohols or hydrous lower aliphatic alcohols, and, in the entire composition, can be generally used for foods. The addition of the raw materials used does not affect the effect of the present invention.

【0014】[0014]

【実施例】スピルリナは塩水アルカリ状態でバッチ式に
培養しスプレードライなど公知の方法で乾燥させた粉末
を用う。補気性生薬のうち、人参の乾燥細切物の1Kg
を30%エタノール5lで3時間加熱抽出し、この操作
を2回繰返して抽出液を合する。冷後ろ過したろ液を減
圧下200gにまで濃縮し軟稠のエキスを作る。甘草、
霊芝についても同様の方法で抽出物を得る。
[Examples] As spirulina, use is made of a powder which is cultivated in a batch method in an alkaline state of salt water and dried by a known method such as spray drying. 1 kg of dried carrot shreds, among the herbal medicines
Is extracted with 5 l of 30% ethanol for 3 hours, and this operation is repeated twice to combine the extracts. The filtrate after cooling is concentrated under reduced pressure to 200 g to make a soft extract. licorice,
An extract is obtained in the same manner for Reishi.

【0015】以上の各原料を用い、以下の処方により1
粒0.2gの素粒を作る。 素粒100g中の各原材料量(数字は重量%) スピルリナ 70.0 人参エキス 0.5 甘草エキス 1.0 霊芝エキス 0.5 精製大豆油(粘結剤) 3.0 乾燥馬鈴薯澱粉(分散剤) 残 量
Using each of the above raw materials, the following formulation 1
Make an elementary grain of 0.2g. Amount of each raw material in 100 g of grain (number is% by weight) Spirulina 70.0 Carrot extract 0.5 Licorice extract 1.0 Reishi extract 0.5 Refined soybean oil (binder) 3.0 Dry potato starch (dispersion) Remaining amount

【0016】[0016]

【試験例1】実施例の素粒を健康な10人のボランティ
ア(41〜61才、男女各5名)に1日30粒ずつ4週
間継続摂取せしめ、摂取前、摂取開始2週間後、同じく
4週間後に検査して、血液中のIFNγ産生及び2−5
A(2′5′オリゴアデニル酸)合成酵素活性の推移を
みた。結果を表1及び表2に示した。
[Test Example 1] 10 healthy volunteers (41 to 61 years old, 5 males and 5 females) were continuously ingested with 30 granules a day for 4 weeks, and the same as before, 2 weeks after the start of ingestion. 4 weeks later, IFNγ production in blood and 2-5
A transition of the activity of A (2'5 'oligoadenylic acid) synthase was observed. The results are shown in Tables 1 and 2.

【0017】なおIFNγ産生は採血血液から作製した
測定用サンプルにつき、ヒト羊膜細胞、シンドビスウイ
ルス(Sindobis virus)50%CPE
(細胞変性効果)抑制によるバイオアッセイ法により、
2−5A合成酵素活性はセンダイウイルス刺激20時間
後のそれを同酵素活性測定用ラジオイムノアッセイキッ
トによりそれぞれ測定した。
IFNγ production was carried out using human amniotic cells and Sindbis virus (Sindobis virus) 50% CPE for measurement samples prepared from blood samples.
(Cytopathic effect) By bioassay by suppression,
The 2-5A synthase activity was measured 20 hours after Sendai virus stimulation by a radioimmunoassay kit for measuring the enzyme activity.

【0018】[0018]

【試験例2】実施例の素粒を、アトピー体質者でとくに
強い自己抑制時に皮膚炎症状が増悪する3名のボランテ
ィア(8才〜14才、女子3名)に1日18粒ずつ4週
間継続摂取せしめ、摂取前後の血清中IgE値の推移と
皮膚炎状態の変化をみた。結果を表3に示した。
[Test Example 2] 18 volunteers a day for 18 weeks a day for 4 volunteers (8 to 14 years old, 3 females) who have atopic constitution and whose exacerbation of skin inflammation occurs during strong self-inhibition After continuous ingestion, changes in serum IgE value and changes in dermatitis state before and after ingestion were observed. The results are shown in Table 3.

【0019】また血清中IgE値の測定は、ラジオイム
ノアッセイ(RIA)法により行ない、皮膚状態は本人
の自覚症状を次の4段階について問い、摂取前後で2段
階以上改善あったものを有効、1段階改善あったものを
やや有効とした。 (皮膚の状態)いらいらが高じたとき、 1.発赤がひどく、我慢できないほどかゆい。 2.発赤があるが、かゆさは我慢できる。 3.発赤は目立たず、かゆさは僅かにむずむずする程
度。 4.発赤やかゆみを自覚しない。
The serum IgE value was measured by the radioimmunoassay (RIA) method. Regarding the skin condition, the subjective symptom of the person was asked about the following 4 stages, and the one that was improved by 2 stages or more before and after ingestion was effective. Those that had stage improvement were considered to be slightly effective. (Skin condition) When irritation is high: 1. The redness is terrible and itching that I can't stand. 2. There is redness, but I can bear the itchiness. 3. Redness is not noticeable and itching is slightly itchy. 4. Not aware of redness and itching.

【0020】以上の試験例1及び試験例2で、試験期間
前後のボランティア各人血液の一般的な生化学的諸検査
値は全て正常に推移しており、注意すべき変動はみられ
なかった。
In the above-mentioned Test Example 1 and Test Example 2, all the general biochemical test values of the blood of each volunteer before and after the test period were normal, and there were no noticeable fluctuations. .

【0021】表1、表2、表3の結果にみられるとお
り、本発明組成物は、高い再現性でIFNγや2−5A
合成酵素を誘導し、またIgE過剰産生を抑制したりす
ることで、有形無形のストレス侵襲へのからだの耐性を
よく向上せしめる。
As can be seen from the results of Table 1, Table 2 and Table 3, the composition of the present invention has a high reproducibility and is suitable for IFNγ and 2-5A.
By inducing synthase and suppressing IgE overproduction, the body's resistance to tangible and intangible stress invasion can be improved well.

【0022】[0022]

【発明の効果】本発明の食品組成物は、スピルリナを主
成分としながら、その摂取による機能発現性は、スピル
リナ単味摂取の場合に比し格段に高く、その現われも、
対処法が不明に近いストレスへの耐性賦活、すなわちス
トレスを軽減し得る点でぬきんでている。構成各原料は
何れも食用を可とされるものばかりであり、各試験例に
おいても、自他覚的また血液検査的に、副作用らしきき
ざしは全くみられなかった。
The food composition of the present invention contains spirulina as a main component, but the function expression by ingestion thereof is significantly higher than in the case of ingestion of spirulina alone, and the appearance thereof is
It is clear that it is possible to relieve stress, that is, to reduce stress, for which the treatment method is unclear. All of the constituent raw materials were all edible, and in each test example, no signs of side effects were observed subjectively or by blood tests.

【0023】従って近代化がさらに進む生活の場におい
て、酷使度が増す健康維持機能の疲労を、その摂取によ
り、安全に効果的に軽減することができる。
Therefore, in a place of living where modernization is further advanced, fatigue of the health maintenance function, which is overused, can be safely and effectively reduced by ingesting it.

【0024】[0024]

【表1】 [Table 1]

【0025】[0025]

【表2】 [Table 2]

【0026】[0026]

【表3】 [Table 3]

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 スピルリナに複数の補気性生薬を配合
したストレス対応食品。
1. A stress-compatible food comprising spirulina and a plurality of aspirating crude drugs.
【請求項2】 複数の補気性生薬が人参、甘草、霊芝
のセットである請求項1のストレス対応食品。
2. The stress-responsive food according to claim 1, wherein the plurality of aspirative crude drugs is a set of carrot, licorice, and ganoderma lucidum.
JP7184605A 1995-06-16 1995-06-16 Food for stress Pending JPH09202A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7184605A JPH09202A (en) 1995-06-16 1995-06-16 Food for stress

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7184605A JPH09202A (en) 1995-06-16 1995-06-16 Food for stress

Publications (1)

Publication Number Publication Date
JPH09202A true JPH09202A (en) 1997-01-07

Family

ID=16156148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7184605A Pending JPH09202A (en) 1995-06-16 1995-06-16 Food for stress

Country Status (1)

Country Link
JP (1) JPH09202A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514668A (en) * 2003-12-18 2007-06-07 ユニリーバー・ナームローゼ・ベンノートシヤープ How to reduce the effects of stress in skin diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514668A (en) * 2003-12-18 2007-06-07 ユニリーバー・ナームローゼ・ベンノートシヤープ How to reduce the effects of stress in skin diseases

Similar Documents

Publication Publication Date Title
Singh et al. Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview
US20040043056A1 (en) Diet composition comprising raw foods and dietary fibers
US20030198697A1 (en) Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
Choi et al. Immunostimulatory activity of isoflavone-glycosides and ethanol extract from a fermented soybean product in human primary immune cells
Subhathra et al. A study to assess the prevalence of anemia among women in a selected urban area in Coimbatore district
Sharma et al. Honey as Potential Cosmeceutical Agent and Functional Food
CN101810679A (en) Polyunsaturated fatty acid soft capsule and preparation method thereof
JPH09202A (en) Food for stress
CN106722258A (en) A kind of astaxanthin colla corii asini cake and preparation method thereof
JPH1070A (en) Processed foods useful for beauty and health
CN101485456B (en) Throat-clearing and oxidation-resisting health-care functional foodstuffs
Yonei et al. A placebo-controlled, randomized, single-blind, parallel-group comparative study to evaluate the anti-glycation effect of a functional soymilk beverage supplemented with rice bran/rice bran oil
JP7756406B1 (en) Stress-relieving composition
Rashmi et al. Upcycling Surinam cherry and spine gourd fruit waste: development of anthelmintic jelly candies using fruit extracts
JP5027740B2 (en) Food composition
Amila et al. The Effect Of Beetroot Biscuits (Beta Vulgaris) On The Hemoglobin Level Of Patients With Pulmonary Tuberculosis
KR102088233B1 (en) Composition for Improving Atopy Dermatitis Using an Extract of Ecklonia cava and an Extract of Sargassum horneri
Fadimatou et al. In vitro antidiabetic potential of two formulated powders of some nutraceutical plants of Cameroon
KR102827352B1 (en) Extract of herbal medicines for enhancing immunity
KR20220114232A (en) Protein bar containing edible insect
JP2025187601A (en) Stress-relieving composition
CN110959824A (en) Tranquilizing composition and preparation method thereof
Hijam et al. Development of functional food multi mix for post-menopausal women
US20240245746A1 (en) Method for regulating immunity by using black hulless barley extract
Zakiah et al. The effect of giving the supplement of Kelor leaves (Moringa oleifera leaves) plus royal jelly to malondialdehid levels in anemic pregnant women in Takalar district